Back to the feed
Disclosure detail

MindMaze Therapeutics Holding SA

23.12.2025 · T1PCN00090

In brief

On 23.12.2025, a person holding the function "Non-executive member of the board of directors" at MindMaze Therapeutics Holding SA disclosed a sale worth CHF 146’250 to SIX Exchange Regulation.

By amount, this ranks #4 of 43 management sales disclosed at MindMaze Therapeutics Holding SA over the previous 12 months.

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Disclosure detail

A non-executive member of the board of directors of MindMaze Therapeutics Holding SA declared a "Sale" transaction on 23.12.2025.

SIX publishes the manager's function, never their name: no individual is named in management transactions.

Transaction date23.12.2025
Issuing companyMindMaze Therapeutics Holding SA
ISINCH1251125998
Transaction sideSale
Management functionNon-executive member of the board of directors
Security typeRegistered shares
Quantity65’000
Unit priceCHF 2.25
AmountCHF 146’250
ExchangeXSWX
Notification IDT1PCN00090

Other MindMaze Therapeutics Holding SA insider transactions

These figures aggregate public disclosures. They are not investment advice.